HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterocyclic rimantadine analogues with antiviral activity.

Abstract
2-(1-Adamantyl)-2-methyl-pyrrolidines 3 and 4, 2-(1-adamantyl)-2-methyl-azetidines 5 and 6, and 2-(1-adamantyl)-2-methyl-aziridines 7 and 8 were synthesized and tested for their antiviral activity against influenza A. Parent molecules 3, 5, and 7 contain the alpha-methyl-1-adamantan-methanamine 2 pharmacophoric moiety (rimantadine). The ring size effect on anti-influenza A activity was investigated. Pyrrolidine 3 was the most potent anti-influenza virus A compound, 9-fold more potent than rimantadine 2, 27-fold more potent than amantadine 1, and 22-fold more potent than ribavirin. Azetidines 5 and 6 were both markedly active against influenza A H2N2 virus, 10- to 20-fold more potent than amantadine. Aziridine 7 was almost devoid of any activity against H2N2 virus but exhibited borderline activity against H3N2 influenza A strain. Thus, it appears that changing the five-, to four- to a three-membered ring results in a drop of activity against influenza A virus.
AuthorsGrigoris Zoidis, Christos Fytas, Ioannis Papanastasiou, George B Foscolos, George Fytas, Elizaveta Padalko, Erik De Clercq, Lieve Naesens, Johan Neyts, Nicolas Kolocouris
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 14 Issue 10 Pg. 3341-8 (May 15 2006) ISSN: 0968-0896 [Print] England
PMID16439137 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Heterocyclic Compounds
  • Rimantadine
Topics
  • Animals
  • Antiviral Agents (chemical synthesis, chemistry, pharmacology)
  • Cells, Cultured
  • Heterocyclic Compounds (chemical synthesis, chemistry, pharmacology)
  • Humans
  • Influenza A Virus, H2N2 Subtype (drug effects)
  • Influenza A Virus, H3N2 Subtype (drug effects)
  • Lethal Dose 50
  • Microbial Sensitivity Tests
  • Rimantadine (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: